Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDrreddyslaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Lupin, Sun Pharma, Dr Reddy's at lower levels: Baliga

      According to Ambareesh Baliga, Independent Market Expert, one can buy Lupin, Sun Pharma and Dr Reddy's Labs at lower levels.

    • Invest in ICICI Bank, Infosys, SBI, RIL, HUL: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that ICICI Bank, Infosys, State Bank of India, Cipla, Dr Reddy's Laboratories, Hindustan Unilever and Reliance Industries are investment opportunities.

    • Bull's Eye: Buy TVS Motor, Escorts, sell EIL, PFC, Bosch

      Jay Thakkar of Sharekhan advises buying Colgate Palmolive with a target of Rs 1986.

    • Prefer IT, pharma space: Siddarth Bhamre

      Siddarth Bhamre of Angel Broking is of the view that one may prefer the IT and the pharma space.

    • Bull's Eye: Sell Bharat Forge, JSW Steel, buy Voltas

      Jay Thakkar of Sharekhan advises buying Dr Reddy's Laboratories with a target of Rs 4390.

    • Accumulate Maruti, HDFC, Dr Reddy's: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that Maruti Suzuki HDFC, Dr Reddy's Laboratories are opportunities to accumulate.

    • Glenmark Pharma can head higher, target Rs 1253: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that Glenmark Pharma is a strong counter as the stock can head higher and test Rs 1253.

    • Buy Dr Reddy's, opportunities in pharma stocks: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Dr Reddy's Laboratories and says that most pharmaceutical companies are buying opportunities on declines.

    • Aurobindo Pharma top pick, says Phani Sekhar

      P Phani Sekhar of Karvy Stock Broking is of the view that Aurobindo Pharma is the top pick from the pharma space.

    • Focus on pharma sector, most buying opportunities: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that most of the pharmaceutical companies are buying opportunities today.

    • Prefer pharma, healthcare space: Pashupati Advani

      According to Pashupati Advani of Globalforay, one may prefer pharma and healthcare space.

    • Dr Reddy's Labs remarkable stock, buy it: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that Dr Reddy's Laboratories is a remarkable stock and recommends buying it.

    • Like PTC India Fin, look at pharma, prefer Infosys: SBI Cap

      Mahantesh Sabarad of SBI Capital Securities likes PTC India Financial Services from the NBFC space and feels that Dr Reddy's Laboratories and Biocon can do substantially well from the pharma space.

    • Buy Dr Reddy's Laboratories, advises Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Dr Reddy's Laboratories as the stock may rally further.

    • Pharma will be expensive, may outperform mkt: Sanjay Sinha

      Sanjay Sinha, Founder at Citrus Advisors is of the view that pharma sector will continue to be expensive but may outperform the broader market.

    • Dr Reddy's Laboratories good investment bet: Sukhani

      Sudarshan Sukhani of s2analytics.com feels that Dr Reddy's Laboratories is a good investment bet.

    • Consider Dr Reddy's Labs in portfolio: Deepak Shenoy

      Deepak Shenoy, Founder of Capitalmind is of the view that one may consider Dr Reddy's Laboratories in the portfolio.

    • Hold Dr Reddy's Labs, add on correction: Deven Choksey

      Deven Choksey of KR Choksey Shares & Securities is of the view that one can hold Dr Reddy's Laboratories in the portfolio and feels that one may add the stock on dips.

    • Accumulate Dr Reddy's Labs on every decline: Bhavesh Gandhi

      Bhavesh Gandhi of India Infoline is of the view that one can acumulate Dr Reddy's Laboratories on every decline.

    • Positively biased in Dr Reddy's Labs: Mehraboon Irani

      Mehraboon Irani of Nirmal Bang Securities is positively biased in Dr Reddy's Laboratories.

    • Hold Dr Reddy's Laboratories, says Hemen Kapadia

      Hemen Kapadia of KR Choksey Securities is of the view that one may stay invested in Dr Reddy's Laboratories.

    • Prefer Kotak Bank, Maruti, Dr Reddy's: Phani Sekhar

      Phani Sekhar of Karvy Stock Broking is of the view that one may prefer Kotak Mahindra Bank, Maruti Suzuki and Dr Reddy‘s Laboratories.

    • Look at Dr Reddy's Laboratories: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may look at buying Dr Reddy's Laboratories if the stock stabilises.

    • Super Six short term picks for July 22

      Sameet Chavan of Angel Broking advises buying HCL Technologies with a target of Rs 1010.

    • Dr Reddy's may test Rs 4100 in 6-8 months: Rahul Mohindar

      Rahul Mohindar of viratechindia.com is of the view that Dr Reddy's Laboratories may test Rs 4100 in 6-8 months.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347